Search Results - Bedrick, Ed

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    INST OX‐05‐024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial

    INST OX‐05‐024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial by Patt, Yehuda Z., Murad, Waheed, Fekrazad, Mohammed H., Baron, Ari D., Bansal, Pranshu, Boumber, Yanis, Steinberg, Kim, Lee, Sang‐Joon, Bedrick, Ed, Du, Ruofei, Lee, Fa Chyi

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL)

    A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL) by Willman, Cheryl L., Kang, Huining, Potter, Jeffrey W., Harvey, Richard C., Atlas, Susan R., Bedrick, Ed, Helman, Paul, Veroff, Robert L., Chen, I.-Ming, Carroll, Andrew J., Ar, Kerem, Xu, Yuexian, Murphy, Sharon B., Bhojwani, Deepa, Moskowitz, Naomi, Carroll, William L., Camitta, Bruce

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: